HIMS - Hims Hers Health - Stock Forecast

Consumer Defensive - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HIMS is currently covered by 7 analysts with an average price target of $68.47. This is a potential upside of $18.01 (35.69%) from yesterday's end of day stock price of $50.46.

Hims Hers Health's activity chart (see below) currently has 34 price targets and 62 ratings on display. The stock rating distribution of HIMS is 39.47% BUY, 44.74% HOLD and 15.79% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.56% with an average time for these price targets to be met of 364.07 days.

Highest price target for HIMS is $68, Lowest price target is $30, average price target is $29.

Most recent stock forecast was given by RYAN MACDONALD from NEEDHAM on 23-Jun-2025. First documented stock forecast 12-Feb-2021.

Currently out of the existing stock ratings of HIMS, 15 are a BUY (39.47%), 17 are a HOLD (44.74%), 6 are a SELL (15.79%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$65

22 days ago
(23-Jun-2025)

3/4 (75%)

$60.4 (1313.04%)

91

Sell

$30

$-17.89 (-37.36%)

$27

2 months 9 days ago
(06-May-2025)

9/9 (100%)

$25.4 (552.17%)

840

Hold

$33

$-14.89 (-31.09%)

$33

2 months 9 days ago
(06-May-2025)

8/8 (100%)

$28.4 (617.39%)

695

Hold

$40

$-7.89 (-16.48%)

$40

2 months 9 days ago
(06-May-2025)

5/5 (100%)

$35.4 (769.57%)

345

Hold

$39

$-8.89 (-18.56%)

$35

2 months 9 days ago
(06-May-2025)

4/4 (100%)

$34.4 (747.83%)

73

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HIMS (Hims Hers Health) average time for price targets to be met?

On average it took 364.07 days on average for the stock forecasts to be realized with a an average price target met ratio 76.56

Which analyst has the current highest performing score on HIMS (Hims Hers Health) with a proven track record?

RYAN MACDONALD

Which analyst has the most public recommendations on HIMS (Hims Hers Health)?

Ryan Macdonald works at NEEDHAM and has 28 price targets and 21 ratings on HIMS

Which analyst is the currently most bullish on HIMS (Hims Hers Health)?

Maria Ripps with highest potential upside - $20.11

Which analyst is the currently most reserved on HIMS (Hims Hers Health)?

Sean Wieland with lowest potential downside - -$41.89

Hims Hers Health in the News

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers, Sarepta, and Petco and Encourages Investors to Contact the Firm

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Hims & Hers Health, Inc. (NYSE: HIMS), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), and Petco Health and Wellness Company, Inc. (NASDAQ:WOOF). Stockholders have until...

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline. SO...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?